Anastrozole 1 MG Oral Tablet [Arimidex] — RxCUI 151124
RxNorm drug concept · Semantic branded drug
RxCUI 151124
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI151124
Official nameAnastrozole 1 MG Oral Tablet [Arimidex]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asArimidex 1 MG Oral Tablet
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)163 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Anastrozole: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Great question. After menopause, your body still makes small amounts of estrogen through an enzyme called aromatase — and many breast cancers use that estrogen as fuel to grow. Ana...
- What exactly is anastrozole doing in my body to fight breast cancer?
- You can take it either way — with or without food. Food does slow down how quickly your body absorbs it, but the total amount that gets into your system stays the same. Pick whatev...
- Can I take anastrozole with food, or does it have to be on an empty stomach?
🕸️ Concept Web — How Anastrozole 1 MG Oral Tablet [Arimidex] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Anastrozole 1 MG Oral Tablet [Arimidex]
RxCUI 151124 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Anastrozole
84857IN
-
Anastrozole
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Arimidex
262485BN
-
Arimidex
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Anastrozole Oral Tablet
370588SCDF -
Anastrozole Oral Product
1157702SCDG -
Anastrozole Pill
1157703SCDG -
Anastrozole Oral Tablet [Arimidex]
367866SBDF -
Arimidex Oral Product
1170752SBDG -
Arimidex Pill
1170753SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Anastrozole Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Anastrozole 1 MG Oral Tablet
199224SCD -
Anastrozole 1 MG
315382SCDC -
Anastrozole 1 MG [Arimidex]
564931SBDC
-
Anastrozole 1 MG Oral Tablet
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Anastrozole 1 MG Oral Tablet
SCD · 199224 -
Anastrozole 1 MG
SCDC · 315382 -
Anastrozole Oral Tablet
SCDF · 370588 -
Anastrozole Oral Product
SCDG · 1157702 -
Anastrozole Pill
SCDG · 1157703
Brand-Name Concepts
-
Anastrozole 1 MG [Arimidex]
SBDC · 564931 -
Anastrozole Oral Tablet [Arimidex]
SBDF · 367866 -
Arimidex Oral Product
SBDG · 1170752 -
Arimidex Pill
SBDG · 1170753 -
Arimidex
BN · 262485
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 151124 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 62559-0670-30 | 30 TABLET in 1 BOTTLE (62559-670-30) | ARIMIDEX | ANI Pharmaceuticals, Inc. | 2018-06-26 |
Observed labelers:
ANI Pharmaceuticals, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$52.5668
Range $52.5668–$52.5668
· middle 50% $52.5668–$52.5668
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.